Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 4/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.41 |
| ▸ | PI4KA | P42356 | 2/20 | 0.41 |
| ▸ | PI4K2B | Q8TCG2 | 2/20 | 0.41 |
| ▸ | PI4K2A | Q9BTU6 | 2/20 | 0.41 |
| ▸ | PI4KB | Q9UBF8 | 2/20 | 0.41 |
| ▸ | DPP4 | P27487 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.41 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.41 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.41 |
| ▸ | GAPDH | P04406 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.41 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.41 |
| ▸ | STAT6 | P42226 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.41 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5179761 | 0.85 | ABCB1 (0.51) | ADORA3ADORA2API4KAPI4K2BPI4K2A | |
| SCHEMBL441536 | 0.85 | EGFR (0.47) | ADORA3ADORA2API4KAPI4K2BPI4K2A | |
| SCHEMBL31644935 | 0.85 | EGFR (0.47) | ADORA3ADORA2API4KAPI4K2BPI4K2A | |
| SCHEMBL6426189 | 0.84 | SLC28A2 (0.43) | ADORA3ADORA2API4KAPI4K2BPI4K2A | |
| SCHEMBL30041710 | 0.81 | DOT1L (0.45) | ADORA3ADORA2API4KAPI4K2BPI4K2A | |
| Phosphoric Acid SCHEMBL16070005 | 0.81 | ADORA3 (0.42) | ADORA3ADORA2API4KAPI4K2BPI4K2A | |
| SCHEMBL1271977 | 0.81 | CA1 (0.44) | ADORA3ADORA2API4KAPI4K2BPI4K2A | |
| SCHEMBL9501856 | 0.81 | EGFR (0.43) | ADORA3ADORA2API4KAPI4K2BPI4K2A | |
| SCHEMBL2463541 | 0.80 | ADORA3 (0.50) | ADORA3ADORA2API4KAPI4K2BPI4K2A | |
| SCHEMBL29655156 | 0.80 | ADORA3 (0.50) | ADORA3ADORA2API4KAPI4K2BPI4K2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014018862-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING A HEAT SHOCK PROTEIN INHIBITOR AND A|PURINE DE NOVO SYNTHESIS INHIBITOR FOR TREATING RHEUMATOID ARTHRITIS OR CANCER | CORNING INCORPORATED (US) | 2014-01-30 | — | — | WO | claimed |
| WO-2014018862-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING A HEAT SHOCK PROTEIN INHIBITOR AND A|PURINE DE NOVO SYNTHESIS INHIBITOR FOR TREATING RHEUMATOID ARTHRITIS OR CANCER | CORNING INCORPORATED (US) | 2014-01-30 | — | — | WO | disclosed |
| EP-2668506-A1 | SEED TRAIT PREDICTION BY ACTIVITY-BASED PROTEIN PROFILING | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2013-12-04 | — | — | EP | disclosed |
| EP-2537027-A1 | METHODS RELATED TO CASEIN KINASE II (CK2) INHIBITORS AND THE USE OF PURINOSOME-DISRUPTING CK2 INHIBITORS FOR ANTI-CANCER THERAPY AGENTS | Corning Incorporated (US) | 2012-12-26 | — | — | EP | disclosed |
| WO-2012100963-A1 | SEED TRAIT PREDICTION BY ACTIVITY-BASED PROTEIN PROFILING | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2012-08-02 | — | — | WO | disclosed |
| US-20110207789-A1 | METHODS RELATED TO CASEIN KINASE II (CK2) INHIBITORS AND THE USE OF PURINOSOME-DISRUPTING CK2 INHIBITORS FOR ANTI-CANCER THERAPY AGENTS | CORNING INCORPORATED | 2011-08-25 | — | — | US | disclosed |
| WO-2011103224-A1 | METHODS RELATED TO CASEIN KINASE II (CK2) INHIBITORS AND THE USE OF PURINOSOME-DISRUPTING CK2 INHIBITORS FOR ANTI-CANCER THERAPY AGENTS | CORNING INCORPORATED (US) | 2011-08-25 | — | — | WO | disclosed |
| US-7264809-B1 | Methods of inhibiting platelet activation and recruitment | IMMUNEX CORPORATION (US) | 2007-09-04 | — | — | US | disclosed |
| EP-0698089-B1 | NUCLEIC ACID ENCODING AMP-ACTIVATED PROTEIN KINASE | ASTRAZENECA AB (SE) | 2007-03-14 | — | — | EP | disclosed |
| US-7078209-B2 | CAK inhibitors and uses thereof | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2006-07-18 | — | — | US | disclosed |
| WO-2002098876-A1 | CAK INHIBITORS AND USES THEREOF | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2002-12-12 | — | — | WO | disclosed |
| EP-1123306-A4 | INHIBITORS OF PLATELET ACTIVATION AND RECRUITMENT | IMMUNEX CORP (US) | 2002-07-03 | — | — | EP | disclosed |
| US-20020002277-A1 | Inhibitors of platelet activation and recruitment | IMMUNEX CORPORATION | 2002-01-03 | — | — | US | disclosed |
| EP-1123306-A1 | INHIBITORS OF PLATELET ACTIVATION AND RECRUITMENT | IMMUNEX CORPORATION (US) | 2001-08-16 | — | — | EP | disclosed |
| US-6258547-B1 | ENZYMATIC POLYPEPTIDE; FOR TREATMENT OF HYPERCHOLESTEROLAEMIA | ZENECA LIMITED (GB) | 2001-07-10 | — | — | US | disclosed |
| WO-2000023459-A1 | INHIBITORS OF PLATELET ACTIVATION AND RECRUITMENT | IMMUNEX CORPORATION (US) | 2000-04-27 | — | — | WO | disclosed |
| WO-2000023094-A2 | METHODS OF INHIBITING PLATELET ACTIVATION AND RECRUITMENT | IMMUNEX CORPORATION (US) | 2000-04-27 | — | — | WO | disclosed |
| EP-0690924-A1 | ANTI-MICROBIAL AGENTS AND SCREENING METHOD THEREFOR | THE UNIVERSITY OF DUNDEE, UNIVERSITY COURT (GB) | 1996-01-10 | — | — | EP | disclosed |
| WO-1994028116-A1 | NUCLEIC ACID ENCODING AMP-ACTIVATED PROTEIN KINASE | ZENECA LIMITED (GB) | 1994-12-08 | — | — | WO | disclosed |
| WO-1994023059-A2 | ANTI-MICROBIAL AGENTS AND SCREENING METHOD THEREFOR | THE UNIVERSITY COURT OF THE UNIVERSITY OF DUNDEE (GB) | 1994-10-13 | — | — | WO | disclosed |